Analysed Gossamer Bio Inc (GOSS:NASDAQ) News Sources
Gossamer Bio (GOSS) Reports Topline Phase 3 Results for Seralutinib in Pulmonary Arterial Hypertension
Yahoo Finance
Gossamer Bio’s Phase 3 PROSERA PAH Trial Misses Primary Endpoint Despite Numerical 6MWD Gain
Yahoo Finance
BREAKING: Gossamer Bio Investors Should Contact Block & Leviton to Potentially Recover ...
The Caledonian-Record
Gossamer Bio Misses Primary Endpoint Threshold on Pulmonary Arterial Hypertension Drug Study
MarketWatch
What is the current price of Gossamer Bio Inc (GOSS:NASDAQ)?
The current price of Gossamer Bio Inc (GOSS:NASDAQ) is $0.3801.
Gossamer Bio Inc (GOSS:NASDAQ) absolute price change since previous trading day?
The absolute price change of Gossamer Bio Inc (GOSS:NASDAQ) since the previous trading day is $-0.04.
Gossamer Bio Inc (GOSS:NASDAQ) percentage price change since previous trading day?
The percentage price change of Gossamer Bio Inc (GOSS:NASDAQ) since the previous trading day is -9.50%.
What is This Week's average sentiment score for Gossamer Bio Inc (GOSS:NASDAQ)?
This Week's average sentiment score for Gossamer Bio Inc (GOSS:NASDAQ) is 56 out of 100.
What is This Week's average sentiment for Gossamer Bio Inc (GOSS:NASDAQ)?
This Week's sentiment for Gossamer Bio Inc (GOSS:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.